Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
Top Cited Papers
Open Access
- 30 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 611337
- https://doi.org/10.3389/fimmu.2020.611337
Abstract
The mucosal immune system is the largest component of the entire immune system, having evolved to provide protection at the main sites of infectious threat: the mucosae. As SARS-CoV-2 initially infects the upper respiratory tract, its first interactions with the immune system must occur predominantly at the respiratory mucosal surfaces, during both inductive and effector phases of the response. However, almost all studies of the immune response in COVID-19 have focused exclusively on serum antibodies and systemic cell-mediated immunity including innate responses. This article proposes that there is a significant role for mucosal immunity and for secretory as well as circulating IgA antibodies in COVID-19, and that it is important to elucidate this in order to comprehend especially the asymptomatic and mild states of the infection, which appear to account for the majority of cases. Moreover, it is possible that mucosal immunity can be exploited for beneficial diagnostic, therapeutic, or prophylactic purposes.Keywords
This publication has 41 references indexed in Scilit:
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgGProceedings of the National Academy of Sciences of the United States of America, 2013
- Secretory immunity with special reference to the oral cavityJournal of Oral Microbiology, 2013
- Mucosal Vaccines: An OverviewPublished by Elsevier BV ,2005
- Collection and Processing of Human Mucosal SecretionsPublished by Elsevier BV ,2005
- Paucity of Antigen-Specific IgA Responses in Sera and External Secretions of HIV-Type 1-Infected IndividualsAIDS Research and Human Retroviruses, 2004
- Bronchus-Associated Lymphoid Tissue (BALT) Is Not Present in the Normal Adult Lung but in Different DiseasesPathobiology, 2000
- Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses.JCI Insight, 1997
- Human immune responses to influenza virus vaccines administered by systemic or mucosal routesVaccine, 1995
- Anti-inflammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgG-mediated complement activationEuropean Journal of Immunology, 1989
- Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infectionEpidemiology and Infection, 1985